Stock Events

Stock Events

Search...

Galmed Pharmaceuticals (GLMD) Q2 2023 Earnings

9AugConfirmed

Jan 23

Q4 2022

Q1 2023

Q2 2023

-1.5

-1.03

-0.57

-0.1

Details

Expected EPS

-0.34

Actual EPS

-0.95

Surprise EPS

-0.61

Surprise Percent

+179.41%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -0.95 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.